U.S. Ophthalmic Sutures Market - By Type, By Material, By Coating, By Material Structure, By Absorption, By Application, By End Use - Forecast, 2026-2035

U.S. Ophthalmic Sutures Market Size

The U.S. ophthalmic sutures market was valued at USD 399.9 million in 2025. The market is expected to reach from USD 428.5 million in 2026 to USD 560.1 million in 2035, growing at a CAGR of 3% during the forecast period, according to the latest report published by Global Market Insights Inc. This can be attributed to the increasing demand for advanced eye surgery, the rise in the prevalence of ophthalmic disorders, and the increasing adoption of minimally invasive procedures.

The U.S. ophthalmic sutures market provides critical surgical solutions to hospitals, ambulatory surgical centers, and specialized ophthalmology clinics, enabling precise wound care, improved surgical outcomes, and enhanced procedural efficiency across cataract, corneal, retinal, and glaucoma-related interventions. The market is driven by rising surgical volumes, growing adoption of minimally invasive ophthalmic procedures, and the demand for advanced absorbable and non-absorbable sutures engineered for superior handling, low tissue reactivity, and predictable postoperative healing.
 

In this competitive landscape, leading players such as Ethicon (J&J), Medtronic, Corza Medical, B. Braun, and Mani strengthen their positions through continuous product innovation, robust U.S. distribution channels, and targeted R&D investments focused on high-performance ophthalmic suturing technologies. These companies leverage long-standing surgeon relationships, diversified product portfolios, and strategic collaborations to address the increasing need for reliable, high-precision ophthalmic sutures. Their sustained efforts contribute to advancing surgical quality while reinforcing market leadership in the rapidly evolving U.S. eye-care sector.
 

The market has increased from USD 296.5 million in 2022 and reached USD 371 million in 2024. The U.S. ophthalmic sutures market is driven by a combination of clinical, demographic, and technological factors that continue to drive demand for high-precision suturing solutions across ophthalmic care settings. One of the primary drivers is the growing burden of age-related eye diseases, including cataracts, glaucoma, diabetic retinopathy, and corneal disorders.
 

As the U.S. population ages and chronic conditions become more prevalent, the volume of ophthalmic surgeries has increased steadily, directly boosting the need for reliable suturing materials. Additionally, advancements in microsurgical techniques and the growing preference for minimally invasive ophthalmic procedures are driving demand for specialized sutures that offer superior handling, reduced tissue trauma, and predictable healing profiles.
 

Another major driver is the expansion of ambulatory surgical centers (ASCs), which perform a large share of cataract and corneal surgeries in the U.S. Their focus on efficiency, faster recovery, and cost-effective care supports the adoption of advanced suturing products optimized for precision and high procedural throughput. Furthermore, rising expectations for visual outcomes and postoperative safety have prompted surgeons to shift toward advanced suture technologies that ensure stability and minimize complications.
 

Technological innovation, including improved materials, refined absorbability profiles, and finer gauge sutures tailored for delicate eye tissues, is also shaping market growth. Continued advancements in device-assisted microsurgery further reinforce the need for sutures compatible with modern surgical platforms. Collectively, these factors contribute to sustained demand and long-term growth in the U.S. ophthalmic sutures market.
 

Ophthalmic sutures are specialized surgical threads used to close incisions or repair delicate ocular tissues during eye surgeries such as cataract, corneal, glaucoma, and retinal procedures. Designed for precision and minimal tissue trauma, they ensure proper wound healing, maintain ocular integrity, and support safe, effective postoperative recovery.
 

U.S. Ophthalmic Sutures Market Trends

The key factors driving the growth of the ophthalmic sutures market are the high prevalence and burden of various eye diseases in the U.S., which shapes both current demand and future growth prospects. Chronic conditions like cataract, glaucoma, diabetic retinopathy, and macular degeneration are becoming more common because of an aging population, changing lifestyles, and the growing incidence of systemic disorders such as diabetes.
 

• These conditions often require surgical interventions, including cataract extraction, corneal transplants, glaucoma surgeries, and retinal repairs, all of which rely heavily on precise and reliable ophthalmic sutures to ensure optimal wound closure and postoperative healing. As the number of ophthalmic procedures grows, so does the demand for advanced suturing solutions, including absorbable, non-absorbable, and specialty sutures designed for delicate ocular tissues.
   
• Technological advancements further amplify this demand. Innovations in microsurgical instruments, minimally invasive surgical techniques, and suture materials have improved procedural efficiency, reduced tissue trauma, and enhanced patient outcomes. Surgeons increasingly prefer high-performance sutures compatible with modern ophthalmic devices, including laser-assisted and robotic-assisted systems. This technological integration drives market adoption, as healthcare providers seek reliable, safe, and precise suturing solutions for complex procedures.
   
• Macro-economic factors, such as rising healthcare expenditure, expanding hospital infrastructure, and increased insurance coverage, support market growth by facilitating higher surgical volumes and broader access to advanced eye-care treatments.
   
• On a microeconomic level, factors like patient willingness to invest in premium surgical outcomes, outpatient surgical center expansion, and competitive strategies by leading companies such as Ethicon (J&J) and Medtronic influence market dynamics, fostering innovation and accessibility.
   
• Collectively, these clinical, technological, and economic factors underscore the high burden of chronic eye diseases as a fundamental driver of the market.
   

U.S. Ophthalmic Sutures Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on the type, the U.S. ophthalmic sutures market is bifurcated into natural and synthetic. The synthetic segment has asserted its dominance in the market by securing a significant market share of 69.2% in 2025, driven by high demand for durable, infection-resistant, and minimally reactive materials drives the adoption of synthetic sutures in ophthalmic procedures across the U.S. The segment is expected to exceed USD 393.2 million by 2035, growing at a CAGR of 3.2% during the forecast period.
 

On the other hand, the natural segment is expected to grow with a CAGR of 2.7%. The rising preference for biocompatible, absorbable materials in ophthalmic surgeries drives demand for natural sutures in the U.S. market.
 

• The synthetic sutures segment is primarily driven by their superior biocompatibility, lower tissue reactivity, and predictable absorption rates. Surgeons increasingly prefer synthetic sutures in delicate ophthalmic procedures, such as corneal transplants, cataract surgeries, and vitreoretinal interventions, due to reduced postoperative complications.
   
• Technological advancements in manufacturing have led to enhanced strength, finer needle–suture designs, and specialized coatings, further boosting adoption in premium surgical settings.
   
• Additionally, the rising trend of minimally invasive ophthalmic surgeries in U.S. outpatient centers has increased reliance on synthetic sutures for precision and efficiency.
   
• The natural segment held a revenue of USD 123.2 million in 2025, with projections indicating a steady expansion at a 2.7% CAGR from 2026 to 2035.
   
• The natural sutures segment, although smaller, benefits from its long-standing clinical acceptance and proven safety profile in ocular procedures. Natural sutures, such as silk, are preferred in cases requiring high knot security and specific tissue handling characteristics.
   
• The segment is further supported by routine ophthalmic procedures and cost-sensitive healthcare settings, where natural sutures remain a viable option. Moreover, continuous training programs for ophthalmologists in U.S. hospitals and ASCs encourage familiarity and confidence in using both suture types, sustaining steady demand.
   

Based on material, the U.S. ophthalmic sutures market is classified into nylon, polyproplene, silk, PGA and other materials. The nylon segment dominated the market with a revenue share of 33.7% in 2025 and is expected to reach USD 185.3 million within the forecast period.
 

• The market is dominated by the nylon segment due to its good mechanical properties and versatility in a wide range of ophthalmic procedures. Nylon sutures are a type of non-absorbable suture that are strong and offer excellent tensile strength, making them suitable for delicate corneal, conjunctival, and scleral surgeries.
   
• Their minimal tissue reactivity reduces postoperative inflammation and enhances wound healing, a critical factor in precision-demanding eye surgeries. Additionally, the growing prevalence of cataract and glaucoma surgeries in the U.S., fueled by an aging population and rising diabetic retinopathy cases, directly drives nylon suture demand.
   
• Technological advancements in suture coating, sterilization, and pre-threaded needles further improve procedural efficiency, making nylon the material of choice for ophthalmologists.
   
• Furthermore, increasing training and adoption of minimally invasive ophthalmic techniques emphasize sutures that offer precise handling and minimal tissue trauma, reinforcing the segment’s growth.
   
• The polypropylene segment held a revenue of USD 114.3 million in 2025, with projections indicating a steady expansion at a 3.2% CAGR from 2026 to 2035.
   
• Polypropylene sutures are non-absorbable and highly inert, making them particularly suitable for ophthalmic procedures requiring long-term tissue support. Their resistance to degradation and low tissue reactivity is advantageous in corneal grafts, glaucoma filtration surgeries, and retinal procedures, where suture integrity over extended periods is critical.
   
• The increasing prevalence of complex ophthalmic surgeries, particularly in the aging population and diabetic patients, drives demand for polypropylene sutures. The rise of premium and specialty ophthalmic procedures has also heightened the need for sutures with excellent biocompatibility and long-term stability.
   
• Additionally, polypropylene’s smooth surface reduces tissue drag, minimizing postoperative complications such as inflammation or scarring, which is especially important in delicate ocular surgeries.
   
• The silk segment held a revenue of USD 63.3 million in 2025, with projections indicating a steady expansion at a 2.8% CAGR from 2026 to 2035.
   
• Silk sutures are widely used in ophthalmology due to their excellent handling properties, knot security, and pliability, making them suitable for a variety of ocular procedures, including conjunctival closure and eyelid surgeries. In the U.S., the high prevalence of eye disorders requiring delicate surgical intervention drives consistent demand for silk sutures.
   
• Their natural composition and ease of use make them ideal for procedures where tissue approximation precision is critical. Despite being absorbable over time, silk sutures provide sufficient strength during the initial healing phase, which is vital in post-cataract and corneal surgeries.
   
• The U.S. market also benefits from a growing emphasis on minimally invasive ophthalmic procedures, where silk sutures facilitate rapid, safe, and reliable wound closure with minimal tissue trauma.
   

Based on coating, the U.S. ophthalmic sutures market is classified into coated and uncoated. The uncoated segment dominated the market with a revenue share of 60.6% in 2025 and is expected to reach USD 343.9 million within the forecast period.
 

• The uncoated ophthalmic sutures segment dominates the U.S. market due to its wide clinical acceptance and cost-effectiveness. These sutures are generally simpler in composition, reducing tissue reactivity and minimizing inflammation during ophthalmic procedures.
   
• Their biocompatibility and predictable handling make them the preferred choice for standard surgeries, including cataract, glaucoma, and corneal procedures. The aging U.S. population has led to a rising prevalence of eye diseases such as cataract and diabetic retinopathy, increasing the volume of ophthalmic surgeries and driving demand for uncoated sutures.
   
• Additionally, a growing number of outpatient surgical centers (ASCs) and ambulatory ophthalmology clinics favor uncoated sutures due to their affordability, ease of use, and efficiency in routine surgical workflows.
   
• The coated segment held a revenue of USD 157.5 million in 2025, with projections indicating a steady expansion at a 2.8% CAGR from 2026 to 2035. The coated ophthalmic sutures segment in the U.S. is driven by increasing demand for advanced, high-performance surgical materials that reduce tissue drag, minimize trauma, and accelerate wound healing.
   
• Coated sutures are designed with protective layers, such as silicone or polyglactin coatings, which enhance smooth passage through ocular tissues, improving precision during delicate surgeries like corneal transplants, oculoplastic procedures, and complex vitreoretinal interventions.
   
• The rising preference for minimally invasive eye surgeries has also contributed to the adoption of coated sutures, as surgeons prioritize reduced postoperative inflammation and faster recovery.
   

Based on material structure, the U.S. ophthalmic sutures market is bifurcated into monofilament and multifilament/braided. The monofilament segment dominated the market with a revenue share of 58.7% in 2025 and is expected to reach USD 332.6 million within the forecast period.
 

• The monofilament segment dominates the market due to its superior biocompatibility, low tissue reactivity, and smooth surface, which reduce friction during suturing. These characteristics make monofilament sutures highly preferred in delicate ocular procedures such as cataract, corneal, and vitreoretinal surgeries.
   
• In the U.S., the rising prevalence of age-related eye disorders, including cataracts and glaucoma, directly boosts the demand for monofilament sutures, as they provide better wound-healing outcomes and minimize postoperative complications.
   
• Technological advancements in suture coatings and materials, including absorbable monofilaments with enhanced tensile strength, further enhance procedural efficiency and patient safety, encouraging their adoption in ophthalmic surgical centers.
   
• Additionally, the increasing shift of ophthalmic surgeries to ambulatory surgery centers (ASCs) and outpatient settings in the U.S. drives demand for high-performance sutures that ensure faster procedures and reduced surgical time.
   
• The multifilament/braided segment held a revenue of USD 165.2 million in 2025, with projections indicating a steady expansion at a 2.8% CAGR from 2026 to 2035. The multifilament or braided ophthalmic sutures segment benefits from its flexibility, knot security, and ease of handling, making it suitable for complex ocular procedures that require precise tissue approximation.
   
• In the U.S., the increasing number of corneal transplantations, glaucoma filtering surgeries, and reconstructive ocular procedures drives demand for braided sutures, as their braided structure provides superior tensile strength and minimizes suture slippage.
   
• Rising prevalence of diabetes-related eye complications and trauma-related ophthalmic interventions further fuel the need for multifilament sutures, especially in surgeries that require enhanced handling and knot retention. Technological innovations in coated braided sutures, which reduce tissue drag and improve biocompatibility, also enhance their clinical adoption in ophthalmology.
   

Based on absorption, the U.S. ophthalmic sutures market is classified into absorbable and non-absorbable. The non-absorbable segment dominated the market with a revenue share of 83.2% in 2025 and is expected to reach USD 471.2 million within the forecast period.
 

• The non-absorbable ophthalmic sutures segment dominates the U.S. market due to their high tensile strength, long-term stability, and suitability for complex ocular procedures, including corneal transplants, glaucoma surgeries, and oculoplastic interventions.
   
• Non-absorbable sutures provide precise wound approximation, superior knot security, and minimal tissue reactivity, making them the preferred choice for procedures requiring prolonged suture retention. The growing prevalence of chronic eye disorders, including cataract, glaucoma, and diabetic retinopathy, drives the demand for durable sutures that support optimal surgical outcomes.
   
• Additionally, advancements in synthetic non-absorbable materials like polypropylene and nylon, offering biocompatibility and reduced risk of infection, have strengthened surgeon confidence in their use.
   
• Expansion of ambulatory surgery centers (ASCs) and hospital ophthalmology departments in the U.S. enhances procedural volumes, further boosting non-absorbable suture consumption.
   
• The absorbable segment held a revenue of USD 67 million in 2025, with projections indicating a steady expansion at a 2.5% CAGR from 2026 to 2035. The absorbable ophthalmic sutures segment in the U.S. is primarily driven by the increasing adoption of minimally invasive ocular surgeries and the rising preference for sutures that naturally degrade within the body, eliminating the need for removal.
   
• These sutures are widely used in corneal, retinal, and pediatric ophthalmic procedures, where patient comfort and reduced postoperative visits are critical. The growing aging population in the U.S. also contributes to higher volumes of cataract and glaucoma surgeries, where absorbable sutures help minimize complications and improve healing outcomes.
   
• Additionally, advancements in biodegradable suture materials, including polyglycolic acid– and polyglactin-based options, have enhanced tensile strength, predictability of absorption, and reduced tissue reaction, encouraging ophthalmologists to favor these sutures.
   

Based on application, the U.S. ophthalmic sutures market is classified into cataract surgery, corneal transplantation surgery, glaucoma surgery, vitrectomy, oculoplastic surgery, and other applications. The cataract surgery segment dominated the market with a revenue share of 49.3% in 2025 and is expected to reach USD 285 million within the forecast period.
 

• The cataract surgery segment dominates the U.S. ophthalmic sutures market due to the increasing prevalence of age-related cataracts among the growing geriatric population. According to the CDC, millions of Americans aged 60 and above are affected by cataracts, fueling high surgical volumes annually.
   
• Advances in surgical techniques, such as phacoemulsification and micro-incisional cataract surgery, have improved patient outcomes and reduced recovery times, further increasing the adoption of surgical interventions.
   
• Additionally, outpatient and ambulatory surgical centers (ASCs) have expanded accessibility, making cataract procedures more cost-effective and convenient, which directly drives the demand for ophthalmic sutures. Insurance coverage and government programs for senior citizens also support the rising number of surgeries.
   
• The corneal transplantation surgery segment held a revenue of USD 77.2 million in 2025, with projections indicating a steady expansion at 3.2% CAGR from 2026 to 2035. The segment is driven by increasing cases of corneal blindness and disorders such as keratoconus, corneal dystrophies, and trauma-induced damage in the U.S.
   
• The demand for high-quality, specialty sutures is substantial, as innovations in lamellar keratoplasty and endothelial keratoplasty require precision suturing to ensure graft stability, wound integrity, and minimized postoperative complications.
   
• The use of advanced microsurgical techniques has led to higher success rates, encouraging ophthalmologists to adopt sutures specifically designed for delicate corneal tissues.
   
• Moreover, the robust infrastructure of U.S. eye banks ensures the availability of donor corneas, supporting steady surgical volumes. Rising awareness about corneal donation and government-supported eye health programs also drives procedural frequency.
   
• The glaucoma surgery segment held a revenue of USD 67.1 million in 2025, with projections indicating a steady expansion at 2.8% CAGR from 2026 to 2035. The segment is primarily driven by the high prevalence of glaucoma. According to the CDC (2024), about 3 million Americans have glaucoma, and it is the second leading cause of blindness worldwide, with numbers expected to rise due to an aging population.
   
• Surgical interventions, including trabeculectomy, glaucoma drainage device implantation, and minimally invasive glaucoma surgeries (MIGS), require precise wound closure to maintain intraocular pressure and prevent postoperative complications, driving demand for high-quality ophthalmic sutures.
   
• Technological advancements in microsurgical instruments and the adoption of premium absorbable sutures improve surgical efficiency and patient outcomes, further encouraging their use. Moreover, increasing awareness of glaucoma and routine screenings has led to earlier diagnosis, enabling timely surgical interventions.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the U.S. ophthalmic sutures market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 54.1% in 2025 and is expected to reach USD 308.3 million within the forecast period.
 

• The two largest segments account for over 89.4% of the total market value. The hospitals segment dominates the market due to its capacity to handle high patient volumes and complex ophthalmic procedures. Hospitals are equipped with advanced surgical infrastructure, including state-of-the-art operating rooms and specialized ophthalmic surgical units, which facilitates the adoption of premium sutures and advanced microsurgical techniques.
   
• The presence of skilled ophthalmologists and retina specialists in hospitals enables the execution of complicated procedures such as corneal transplants, glaucoma surgeries, and vitreoretinal interventions, all of which require high-quality sutures.
   
• Additionally, hospitals often manage emergency ophthalmic cases, trauma-related eye injuries, and post-traumatic reconstructions, driving consistent suture usage.
   
• The ambulatory surgical centers segment held a revenue of USD 141.3 million in 2025, with projections indicating a steady expansion at 3% CAGR from 2026 to 2035.
   
• Ambulatory surgical centers (ASCs) are emerging as a critical growth segment in the U.S. ophthalmic sutures market. ASCs provide cost-effective, efficient, and patient-friendly surgical care, especially for routine ophthalmic procedures such as cataract surgeries and minor corneal interventions.
   
• The shift from inpatient hospital procedures to outpatient settings has been accelerated by the need to reduce healthcare costs, improve patient turnover, and enhance surgical accessibility. ASCs are increasingly adopting minimally invasive ophthalmic procedures that require advanced, high-precision sutures, supporting growth in suture demand.
   
• Moreover, the streamlined workflow in ASCs allows for quicker procedure scheduling, attracting patients who prefer shorter recovery times and lower procedural costs compared to hospitals.
   

Looking for region specific data?

Download Free PDF

South Atlantic Ophthalmic Sutures Market

South Atlantic dominated the U.S. ophthalmic sutures market with the highest market share of 19.4% in 2025.
 

• The zone comprises states such as Florida, Georgia, North Carolina, and South Carolina, which collectively have a large aging population. The increasing prevalence of age-related eye disorders, including cataract, glaucoma, and diabetic retinopathy, has led to higher volumes of ophthalmic surgeries, directly boosting demand for sutures.
   
• The South Atlantic zone also hosts numerous well-established hospitals, ambulatory surgical centers, and specialized ophthalmology clinics equipped with advanced surgical infrastructure, supporting the adoption of premium and specialty sutures.
   
• Florida, in particular, is a hub for ophthalmic care and attracts patients from across the U.S. for advanced procedures, creating a concentrated demand pool. Additionally, favorable state-level healthcare policies and insurance coverage, combined with strong reimbursement frameworks for ophthalmic surgeries, enhance access to advanced surgical solutions.
   
• The zone also benefits from a growing number of outpatient surgery centers that perform minimally invasive eye procedures, further increasing suture consumption. Technological adoption, including micro-incisional techniques and high-precision suture materials, is widespread in this zone.
   

Pacific Ophthalmic Sutures Market

Pacific ophthalmic sutures market accounted for USD 52.1 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• The growth in this zone is primarily driven by the increasing prevalence of chronic eye disorders such as cataract, glaucoma, and diabetic retinopathy, particularly among the aging population in California, which is one of the most populous states in the U.S. Advanced healthcare infrastructure and the presence of leading hospitals, academic medical centers, and specialized ophthalmic surgery centers in major urban hubs such as Los Angeles, San Francisco, and Las Vegas facilitate high procedural volumes and the adoption of premium sutures.
   
• Additionally, the zone benefits from a high concentration of skilled ophthalmologists and retina specialists, enabling complex and minimally invasive eye surgeries that rely on advanced suture materials.
   
• The Pacific zone also witnesses rising patient awareness regarding early diagnosis and treatment of eye disorders, contributing to increased surgical interventions.
   
• Furthermore, favorable state-level healthcare initiatives, coupled with expanding ambulatory surgery centers and private eye-care clinics, provide better accessibility to eye-care services, supporting consistent demand for ophthalmic sutures.
   

Northeast Ophthalmic Sutures Market

The Northeast ophthalmic sutures market is anticipated to grow at the highest CAGR of 4% during the analysis timeframe.
 

• The zone has a dense concentration of top-tier hospitals, academic medical centers, and specialized eye-care institutes, which perform high volumes of ophthalmic surgeries, including cataract, corneal, glaucoma, and vitreoretinal procedures.
   
• The presence of a large geriatric population in states such as New York, Massachusetts, and Pennsylvania contributes to a higher prevalence of age-related eye diseases, driving surgical demand. Additionally, the Northeast has higher per capita healthcare expenditure, enabling greater adoption of advanced surgical tools and premium suture materials.
   
• Technological advancements, including minimally invasive techniques, micro-incisional surgery, and innovative suture materials, are rapidly integrated in this zone due to the concentration of research institutions and academic hospitals.
   
• Furthermore, favorable insurance coverage, Medicare reimbursements, and government initiatives promoting eye health programs encourage more patients to undergo ophthalmic procedures, indirectly boosting suture demand.
   

U.S. Ophthalmic Sutures Market Share

The market operates as a moderately concentrated oligopoly, with Ethicon (J&J), Medtronic, Corza Medical, B. Braun, and Mani collectively accounting for 53.1% of the U.S. market share. This competitive structure emphasizes innovation, surgical precision, product quality, and patient safety. These leading players maintain their market positions through extensive product portfolios, including absorbable and non-absorbable sutures, monofilament and braided options, and specialized designs for cataract, glaucoma, corneal, and retinal surgeries. Strong U.S.-based distribution networks, strategic hospital partnerships, and collaborations with ambulatory surgical centers (ASCs) and specialty eye clinics enable timely delivery of advanced suture solutions across the country.
 

Market growth in the U.S. is fueled by the rising prevalence of ocular disorders such as cataracts, glaucoma, and diabetic retinopathy, which drive higher surgical volumes. Companies are investing in research and development to introduce biocompatible, minimally reactive sutures that enhance healing, reduce post-operative complications, and improve patient outcomes. Technological advancements, including pre-loaded suture kits, precision-engineered needle-suture combinations, and bioabsorbable materials, are influencing surgeon preferences.
 

Furthermore, partnerships with hospitals, ASCs, and research institutions support wider adoption and spur innovation in ophthalmic suturing techniques. The increasing shift toward minimally invasive ocular surgeries, rising patient awareness, and government-supported eye care initiatives are encouraging continuous product development. Differentiation in this competitive environment increasingly relies on delivering high-quality, patient-centric, and technologically advanced suture solutions suitable for both hospital and outpatient surgical settings.
 

U.S. Ophthalmic Sutures Market Companies

Few of the prominent players operating in the U.S. ophthalmic sutures industry include:

• Accutome
• Alcon
• Assut Medical
• Aurolab
• B. Braun
• Corza Medical
• DemeTECH
• Ethicon
• FCI Ophthalmics
• Geuder AG
• Mani
• Medtronic
• Peters Surgical
• Rumex International
• Surgical Specialties Corporation
• Teleflex Incorporated
   
• Ethicon (J&J)

Ethicon holds a market share of 17.8%. The company leverages its global reputation and robust R&D capabilities to provide high-quality, biocompatible ophthalmic sutures. Its portfolio includes absorbable and non-absorbable sutures, precision-engineered needles, and preloaded kits, designed to improve surgical efficiency, minimize complications, and enhance patient outcomes. Strong partnerships with hospitals and surgical centers support broad adoption of its solutions.
 

• Medtronic

 Medtronic differentiates itself through innovative suture technologies and integrated solutions for complex ocular procedures. The company focuses on precision, safety, and reliability, underpinned by advanced material science and surgeon-centric design. Extensive distribution and training programs promote adoption across hospitals and specialty centers, ensuring consistent quality and superior surgical outcomes in diverse ophthalmic applications.
 

U.S. Ophthalmic Sutures Industry News:

• In October 2024, Corza Medical launched its Onatec ophthalmic microsurgical sutures at the American Academy of Ophthalmology conference in Chicago. This introduction highlights Corza’s commitment to innovation, offering precise, high-quality solutions for advanced ophthalmic procedures, and reinforcing its presence in the ophthalmic surgery market.
   
• In November 2022, Alcon completed the acquisition of Aerie Pharmaceuticals, Inc., expanding its footprint in the ophthalmic pharmaceutical sector. The acquisition aims to enhance Alcon’s commercial product portfolio, strengthen its market position, and support the development and delivery of innovative eye-care therapies worldwide.
   
• In June 2022, Corza Medical acquired Barron Precision Instruments, LLC (BPI), a founder-owned medical device company specializing in ophthalmic surgery products. This acquisition expanded Corza’s product portfolio and broadened its customer base, enabling the company to better serve the ophthalmic surgical market.
   

The U.S. ophthalmic sutures market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Natural
• Synthetic

Market, By Material

• Nylon
• Polyproplene
• Silk
• PGA
• Other materials

Market, By Coating

• Coated
• Uncoated

Market, By Material Structure

• Monofilament
• Multifilament/Braided

Market, By Absorption

• Absorbable
• Non-absorbable

Market, By Application

• Cataract surgery
• Corneal transplantation surgery
• Glaucoma surgery
• Vitrectomy
• Oculoplastic surgery
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following zones:

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• Northeast
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• West North Central
  • Iowa
  • Kansas
  • Minnesota
  • Missouri
  • Nebraska
  • North Dakota
  • South Dakota
• Pacific
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming